The best Bull and Bear pitches based on recency and number of recommendations.
My toddler just asked, "Where's mom?" and I told him to go ask his mom.
Read the most recent pitches from players about SMLR.
Recs
IndyAnthony
(41.87)
Submitted: 4/12/2021 11:41:56 PM :
Start Price:
$110.00
NASDAQ OTC:SMLR Score:
+1.35
Huuge potential with QuantaFlo healthcare product that measures blood flow in a patient in about 4 minutes time. SaaS-like business model with a mrk cap < $1B at the moment. Could easily be a $10B+ business.
Recs
FoolGrowth4Life
(< 20)
Submitted: 3/13/2021 8:37:26 AM :
Start Price:
$107.25
NASDAQ OTC:SMLR Score:
-0.45
The ability to identify life-threatening diseases early and in asymptomatic patients with high accuracy rates is priceless. To be able to accomplish this feat while contributing to making healthcare costs lower for patients and providers is game-changing. Semler Scientific, Inc. is doing exactly that with their patented QuantaFlo technology and proprietary risk assessment software for physicians and health insurance companies.
Insider Ownership: 26%
Debt- Free
$22M in Cash
Market Cap: under $1B
Forecasted Earnings Growth: 27%
ROCE: 53%, ROA: 40%, ROE: 47%, very fiscally responsible and rewarding to their shareholders
4 New products in different development stages that will continue to expand optionality and revenue streams
Semler scientific is not resting on its laurels and success of QuantaFlo Technology, Software as a Service Platform, and their Wellchec Testing Service for their customers. Instead Semler Scientific is thinking about things in a holistic approach by wanting to build a platform or ecosystem of health products and services that integrate and complement the solutions they have today. Semler Scientific is working with three different private firms to create three different healthcare solutions that are patented, already FDA approved, and will continue to help save lives like QuantaFlo.
The Semler Scientific Ecosystem could grow its revenue streams and customer base tremendously if these solutions can identify potential healthcare risks early like QuantaFlo has, save patients time with healthcare visits, and provide more accurate results. I am confident they will deliver on this type of platform and they also have another internal product being developed which brings the total to four new solutions they will be launching in the future. If Semler can replicate the financial success they have currently with these new products then they could have large compounded growth returns for a long time.
Recs
dschleicher
(81.09)
Submitted: 3/2/2021 2:29:12 PM :
Start Price:
$118.60
NASDAQ OTC:SMLR Score:
-12.20
Great profit margins and lots of optionality
Find the members with the highest scoring picks in SMLR.
mingdom (97.75) Score: +365.13
The Score Leader is the player with the highest score across all their picks in SMLR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| mingdom | 97.75 | 8/13/2018 |
|
5Y | $22.10 | +413.57% | +48.44% | +365.13 | 0 Comment | |
| Paco57 | 64.55 | 8/17/2018 |
|
5Y | $23.00 | +393.48% | +47.36% | +346.12 | 1 Comment | |
| Plasmidologist | 61.11 | 9/24/2018 |
|
5Y | $34.20 | +231.84% | +43.91% | +187.93 | 0 Comment | |
| sublimeinvestor | 39.45 | 9/24/2018 |
|
5Y | $34.20 | +231.84% | +43.91% | +187.93 | 0 Comment | |
| Dreamwolves | 56.23 | 10/3/2018 |
|
1Y | $38.55 | +194.42% | +43.15% | +151.27 | 0 Comment | |
| jerseymike89 | 31.91 | 7/8/2020 |
|
5Y | $44.00 | +157.95% | +33.35% | +124.60 | 0 Comment | |
| LK15833 | 49.31 | 5/12/2020 |
|
5Y | $43.00 | +163.95% | +42.55% | +121.40 | 0 Comment | |
| UnderdogIsHere | < 20 | 7/10/2020 |
|
5Y | $45.60 | +148.90% | +31.98% | +116.92 | 0 Comment | |
| grahamglen3030 | 92.49 | 5/6/2020 |
|
5Y | $43.34 | +161.88% | +45.50% | +116.38 | 0 Comment | |
| Randalf | 47.21 | 5/6/2020 |
|
5Y | $43.34 | +161.88% | +45.50% | +116.38 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
